Prometheus Biosciences In... (RXDX)
NASDAQ: RXDX
· Real-Time Price · USD
199.92
0.18 (0.09%)
At close: Jun 15, 2023, 10:00 PM
Prometheus Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | 1.1M | 653K | 968K | 1.27M | 3.92M | 1.04M | 1.01M | 326K | 760K | 463K | 359K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 1.1M | 653K | 968K | 1.27M | 3.92M | 1.04M | 1.01M | 326K | 760K | 463K | 359K |
Operating Income | -48.7M | -41.33M | -38.38M | -33.97M | -32.1M | -29.94M | -26.79M | -18.85M | -12.22M | -8.56M | -7.47M |
Interest Income | 7.83M | 2.57M | 1.11M | 321K | 30K | 26K | 27K | 37K | 18K | 5K | 3K |
Pretax Income | -40.88M | -38.76M | -37.27M | -33.65M | -32.07M | -29.92M | -27.33M | -19M | -13.95M | -9.21M | -7.83M |
Net Income | -40.88M | -38.76M | -36.17M | -33.33M | -32.04M | -31.61M | -27.33M | -19M | -13.95M | -8.62M | -6.95M |
Selling & General & Admin | 13.39M | 12.04M | 10.27M | 9.32M | 8.09M | 7.42M | 10.25M | 5.62M | 5.22M | 3.72M | 3.17M |
Research & Development | 36.42M | 29.94M | 29.08M | 25.92M | 27.93M | 23.56M | 17.55M | 13.55M | 7.76M | 5.31M | 4.65M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 49.81M | 41.98M | 39.35M | 35.24M | 36.02M | 30.98M | 27.8M | 19.17M | 12.98M | 9.03M | 7.83M |
Interest Expense | n/a | n/a | n/a | 321K | 30K | -1.72M | 13K | 190K | 658K | 637K | 364K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 49.81M | 41.98M | 39.35M | 35.24M | 36.02M | 30.98M | 27.8M | 19.17M | 12.98M | 9.03M | 7.83M |
Income Tax Expense | -233K | -212K | -1.11M | -321K | -30K | 1.7M | n/a | 37K | n/a | -8K | 4K |
Shares Outstanding (Basic) | 47.46M | 42.95M | 41.22M | 39.24M | 39.01M | 38.92M | 38.85M | 38.81M | 36.71M | 26.98M | 26.98M |
Shares Outstanding (Diluted) | 47.46M | 42.95M | 41.22M | 39.24M | 39.01M | 38.92M | 38.85M | 38.81M | 36.71M | 26.98M | 26.98M |
EPS (Basic) | -0.86 | -0.9 | -0.88 | -0.85 | -0.82 | -0.81 | -0.7 | -0.49 | -0.38 | -0.32 | -0.26 |
EPS (Diluted) | -0.86 | -0.9 | -0.88 | -0.85 | -0.82 | -0.81 | -0.7 | -0.49 | -0.38 | -0.32 | -0.26 |
EBITDA | -48.7M | -41.33M | -37.11M | -33.49M | -31.98M | -31.64M | -27.24M | -18.75M | -13.25M | -7.96M | -6.55M |
EBIT | -48.7M | -39.12M | -38.38M | -33.33M | -32.04M | -31.64M | -27.32M | -18.81M | -13.29M | -8.57M | -7.46M |
Depreciation & Amortization | 233K | 212K | 1.28M | 482K | 117K | -1.7M | 78K | 56K | 39K | 30K | 30K |